| TAT-based drug delivery system--new directions in protein delivery for new hopes? | |
| | |
MedLine Citation:
|
PMID: 19413454 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There has been great progress in the use of TAT-based drug delivery systems for the delivery of different macromolecules into cells in vitro and in vivo, thus circumventing the bioavailability barrier that is a problem for so many drugs. There are many advantages to using this system, such as the ability to deliver these cargoes into all types of cells in culture and into all organs in vivo. This system can even deliver cargoes into the brain across the blood-brain barrier. In addition, the ability to target specific intracellular sub-localizations such as the nuclei, the mitochondria and lysosomes further expands the possibilities of this drug delivery system to the development of sub-cellular organelle-targeted therapy. The therapeutic applications seem almost unlimited, and the use of the TAT-based delivery system has extended from proteins to a large variety of cargoes such as oligonucleotides, imaging agents, low molecular mass drugs, nanoparticles, micelles and liposomes. In this review the most recent advances in the use of the TAT-based drug delivery system will be described, mainly discussing TAT-mediated protein delivery and the use of the TAT system for enzyme replacement therapy. |
| | |
Authors:
|
Matan Rapoport; Haya Lorberboum-Galski |
Related Documents
:
|
8207324 - Collagen-based drug delivery and artificial tears. 17722514 - Age-related macular degeneration: a target for nanotechnology derived medicines. 2868094 - Drug delivery to the proximal colon. 16594634 - Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemi... 16961404 - Application of lean manufacturing concepts to drug discovery: rapid analogue library sy... 2688634 - Purification and characterization of an anticonvulsant-induced human cytochrome p-450 c... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Expert opinion on drug delivery Volume: 6 ISSN: 1744-7593 ISO Abbreviation: Expert Opin Drug Deliv Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-05-05 Completed Date: 2009-07-28 Revised Date: 2009-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 101228421 Medline TA: Expert Opin Drug Deliv Country: England |
Other Details:
|
Languages: eng Pagination: 453-63 Citation Subset: IM |
Affiliation:
|
Faculty of Medicine Hebrew University, Department of Cellular Biochemistry and Human Genetics, Jerusalem, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Carriers / chemistry* Drug Delivery Systems / methods* Gene Products, tat / administration & dosage*, metabolism* Humans Models, Biological Nanoparticles / administration & dosage Nucleic Acids / administration & dosage Peptide Nucleic Acids / administration & dosage Proteins / administration & dosage Recombinant Fusion Proteins / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Drug Carriers; 0/Gene Products, tat; 0/Nucleic Acids; 0/Peptide Nucleic Acids; 0/Proteins; 0/Recombinant Fusion Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Parallel recovery in a bilingual aphasic: A neurolinguistic and fMRI study.
Next Document: Retinoids: new use by innovative drug-delivery systems.